‘Other-unproven’: US research and its implications for complementary therapies in the UK
Intended for healthcare professionals
Evidence and practice    

‘Other-unproven’: US research and its implications for complementary therapies in the UK

Andrea Lambell Member of the Federation of Holistic Therapists, registered practitioner with the Complementary and Natural Healthcare Council, PhD student in medical anthropology, Durham University, County Durham, England

An American study has concluded that people with cancer who receive complementary medicine (CM) have a twofold greater risk of death compared with patients who had no CM. The Yale University study is presented as an assessment of ‘complementary’ rather than ‘alternative’ therapies, but this critical analysis suggests it fails to differentiate between the two approaches to the use of unconventional interventions. It also fails to address the complex factors involved in its authors’ question: ‘What patient characteristics are associated with the use of CM for cancer and what is the association of CM with treatment adherence and survival?’.

By considering the US study in the context of conditions and developments in the UK, this article offers insights into ways appropriately trained and regulated complementary therapists could play a useful role in new models of care. It also identifies areas for further investigation.

Cancer Nursing Practice. doi: 10.7748/cnp.2019.e1586

Peer review

This article has been subject to external double-blind peer review and has been checked for plagiarism using automated software

Correspondence

andrea.r.lambell@durham.ac.uk

Conflict of interest

None declared

Lambell A (2019) ‘Other-unproven’: US research and its implications for complementary therapies in the UK. Cancer Nursing Practice. doi: 10.7748/cnp.2019.e1586

Published online: 04 July 2019

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more